About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,806 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,806 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1521-1540 of 10,806 trials

CompletedPREFER (Pacemaker Remote Follow-Up Evaluation and Review)The purpose of the study is to compare remote pacemaker follow-up to current standard of care follow-up.NCT00294645·Scottsdale, Arizona and 44 others CompletedStudy to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR AlterationThis is an open-label, single arm study to study the safety, efficacy and tolerability of Pemigatinib when used on participants with squamous or nonsquamous NSCLC with a…NCT05253807·Los Angeles, California and 35 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedEfficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain InjuryThe SyNAPSe trial will study if giving intravenous (i.v.) progesterone within 8 hours of the injury for a total of 120 hours to severe traumatic brain injury patients improves…NCT01143064·Mobile, Alabama and 155 others

CompletedStudy of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus TrialsThe purpose of this study is to provide anti-hepatitis C virus drugs to patients who received placebo + peginterferon alfa-2a + ribavirin in prior Bristol-Myers Squibb (BMS)…NCT01428063·Montgomery, Alabama and 105 others

CompletedMP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)This study looks at the safety and effectiveness of MP0420 in treating COVID-19 in people who have been hospitalized with the infection.NCT05780463·Tucson, Arizona and 104 others

CompletedStudy of the Safety and Efficacy of AMT-101 in Subjects With PouchitisPhase 2 Study Investigating the Efficacy of AMT-101 in Subjects with Chronic Antibiotic-resistant PouchitisNCT04741087·Bristol, Connecticut and 33 others

CompletedSelexipag (ACT-293987) in Pulmonary Arterial HypertensionThe AC-065A302 (GRIPHON) study is an event-driven Phase 3 study to demonstrate the effect of selexipag on time to first morbidity or mortality event in patients with pulmonary…NCT01106014·Mobile, Alabama and 181 others

CompletedStudy of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in AdultsThis study is designed to test lot consistency of three different manufacturing lots and to generate safety and immunogenicity data of the investigational vaccine administered via…NCT00772109·Hoover, Alabama and 48 others

UnknownNatural Killer Cell (CYNK-001) Infusions in Adults With Multiple MyelomaThis study will find the maximum tolerated dose (MTD) of CYNK-001 which contain NK cells derived from human placental CD34+ cells and culture-expanded.NCT04309084·Denver, Colorado and 3 others

CompletedStudy of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial CancerThe primary objective in Phase I is to evaluate the safety and tolerability of sacituzumab govitecan-hziy (SG) as a single agent administered in 21-day treatment cycles in…NCT01631552·Aurora, Colorado and 11 others

CompletedA Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal CancerThis study will assess the efficacy and safety of continuous oral Xeloda administration in combination with intravenous irinotecan as a first-line treatment in patients with…NCT00048126·Hoover, Alabama and 9 others

TerminatedA Study of ATI-50002 Topical Solution for the Treatment of Alopecia AreataPrimary: • To assess safety, tolerability and efficacy of 2 dose strengths of ATI-50002 Topical Solution, compared to vehicle in subjects with alopecia areata (AA) Secondary: •…NCT03354637·Encinitas, California and 22 others

CompletedEfficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic AsthmaA substance called immunoglobulin E (IgE), which is naturally produced by our body, has a key role in generating asthma attacks.NCT00079937·Birmingham, Alabama and 55 others

CompletedEffects of Changing HIV Therapy at Lower Versus Higher Viral LoadsThis study will look at people who have been taking anti-HIV drugs but still have detectable levels of HIV.NCT00036465·Menlo Park, California and 22 others

CompletedAn Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV MelanomaThe purpose of this study is to assess the objective response rate of lenvatinib in previously treated participants with American Joint Committee on Cancer (AJCC) unresectable…NCT01136967·Birmingham, Alabama and 94 others

WithdrawnhuC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction CarcinomasTo assess the response rate of huC242-DM4 given as an intravenous infusion to patients with metastatic or locally advanced gastric or gastroesophageal junction cancer.NCT00620607·Birmingham, Alabama and 3 others

RecruitingWindow Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)High-grade gliomas (HGGs) are among the most aggressive and treatment-resistant brain tumors.NCT07210632·Nashville, Tennessee

CompletedGlycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)This study is a prospective, 2-arm, randomized controlled trial to determine whether glycemic control, achieved through intensification of treatment, is effective in preventing…NCT00032487·Phoenix, Arizona and 20 others

CompletedTreatment for Improvement of Cellulite Appearance Using Form ApplicatorOpen-label, non-randomized, prospective, multi-center, self-controlled clinical study with masked evaluation.NCT05882721·Sacramento, California and 4 others

TerminatedTIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed TherapyThe purpose of this study is to compare the safety and anti-tumor effect of rociletinib with erlotinib in patients whose tumors have specific EGFR mutations and who have not…NCT02186301·Birmingham, Alabama and 73 others

PreviousPage 77 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville